wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34444212-1D32D1C2-C2C0-49BF-BE40-D7AAE959AF72
Q34444212-1D32D1C2-C2C0-49BF-BE40-D7AAE959AF72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34444212-1D32D1C2-C2C0-49BF-BE40-D7AAE959AF72
Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis.
P2860
Q34444212-1D32D1C2-C2C0-49BF-BE40-D7AAE959AF72
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34444212-1D32D1C2-C2C0-49BF-BE40-D7AAE959AF72
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
db56143a3ad6acedb883ea715f323dfd0a84c3ba
P2860
Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial.